The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Michael Diaz named president, managing physician of Florida Cancer Specialists and Research Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Michael Diaz was named president and managing physician at Florida Cancer Specialists and Research Institute. 

Diaz succeeds Lucio Gordan, who has held the position since 2018.

Diaz joined FCS in 2011 and provides care at two FCS office locations in St. Petersburg. Since November of 2018, he has worked as assistant managing physician for the statewide practice. Diaz serves on the FCS Executive Board and is the FCS director of patient advocacy. 

Gordan is a member of the board of directors for the Community Oncology Alliance and Florida Association of Clinical Oncology. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as chief medical officer of therapeutics and analytics for the statewide practice.

Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
By Sara Willa Ernst and Paul Goldberg
Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.
By Richard M. Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account